
Sign up to save your podcasts
Or
For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/DET865. CME/AAPA credit will be available until August 21, 2025.
Mapping a New Treatment Journey in NF1: New Developments With MEKi for Pediatric and Adult Patients With NF1-Plexiform Neurofibromas
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an independent medical education grant from SpringWorks Therapeutics, Inc.
Disclosure information is available at the beginning of the video presentation.
3.5
2727 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/DET865. CME/AAPA credit will be available until August 21, 2025.
Mapping a New Treatment Journey in NF1: New Developments With MEKi for Pediatric and Adult Patients With NF1-Plexiform Neurofibromas
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an independent medical education grant from SpringWorks Therapeutics, Inc.
Disclosure information is available at the beginning of the video presentation.
133 Listeners
5 Listeners
3 Listeners
3 Listeners
10 Listeners
5 Listeners
11 Listeners
3 Listeners
2 Listeners
4 Listeners
2 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
1,871 Listeners
532 Listeners
2 Listeners
962 Listeners
11 Listeners
2 Listeners
488 Listeners
684 Listeners
277 Listeners
255 Listeners
3,310 Listeners
91 Listeners
1,110 Listeners
191 Listeners
512 Listeners
250 Listeners
366 Listeners